仁度生物：2025年度业绩快报公告

Core Viewpoint - Rendu Biotech announced projected financial results for the year 2025, indicating a total operating revenue of 1.6206 billion yuan and a net profit attributable to the parent company of 9.5091 million yuan [2] Financial Performance - The company expects to achieve total operating revenue of 1.6206 billion yuan in 2025 [2] - The net profit attributable to the parent company is projected to be 9.5091 million yuan for the same year [2]